Diabetes POCT - HbA1c Immunoassay Test Kit
HbA1c diagnostic test is a proprietary point-of-care fluorescence immunoassay (FIA) designed for prompt and accurate in-vitro quantitative measurement
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Brand name
- Optical Q
- Payment Terms
- T/T
- Production method
- OBM
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- diagnostic devices, ivd, poct, fluorescence immunoassay
- Category
- Chemical Reagents & Products
South Korea
| Product name | Diabetes POCT - HbA1c Immunoassay Test Kit | Certification | CE |
|---|---|---|---|
| Category | Chemical Reagents & Products | Material | - |
| Keyword | diagnostic devices , ivd , poct , fluorescence immunoassay | Unit Size | - |
| Brand name | Optical Q | Unit Weigh | - |
| origin | South Korea | Stock | 100000 |
| Supply type | OBM | HS code | 3822 |
Product Information
The Optical Q™ HbA1c diagnostic test is a proprietary point-of-care (POCT) fluorescence immunoassay (FIA) designed for prompt and accurate in-vitro quantitative measurement of HbA1c. The Optical Q™ HbA1c reagent test is the first HbA1c FIA test kit that does not require processing with a centrifuge, allowing for a) quicker results and b) higher accuracy.
Specifications
| Working range | 4.0-15.0 % |
| Reference range | <6.5 % |
| CV | <10% |
| Sample type | Whole Blood |
| Sample volume | 5 μL |
| Loading volume | 100 µL |
| Assay time | 15 minutes |
| Storage condition | Cartridge: 2-30 °C / Detection buffer: 2-8 °C |
| Shelf life | 24 months |
Ordering Information
| Cat No. | Description | Packing Size | Storage Condition |
| OB121-25 | Optical Q HbA1c | 25 Test/Box | Cartridge: 2-30℃ Detection Buffer: 2-8℃ |
- Product Info Attached File
- Verified Certificate
-
B2B Trade
| Price (FOB) | Negotiable | transportation | Air Transportation,Negotiation Other |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | T/T | Shipping time | Negotiable |
- President
- Jeawon Kim, Minyoung Choi
- Address
- Bonbukwan-401, 76, Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Korea
- Product Category
- Other Monitoring & Diagnostic Equipment
- Year Established
- 2019
- Company introduction
-
OptiBio is a South Korean in-vitro diagnostics (IVD) company focused in researching, developing, and manufacturing cutting edge fluorescence immunoassay (FIA) solutions. In 2020, OptiBio was selected by a research fund sponsored by the Bill & Melinda Gates foundation for its unique and dedicated approach to immunoassay.
OptiBio's competitive advantage stems from its strong foundation of experts, each specialized in fields crucial for product development. Our R&D is divided into 3 different teams of scientists and engineers dedicated to the independent development of diagnostic markers, test kits, and analyzers.
Our fundamental approach to in-house specialization allows OptiBio to constantly improve our product performance, customize our solutions based on client feedback, develop new test parameters, and respond to changing market needs.
OptiBio will continue to create, improve, and innovate world-class diagnostic solutions in the field of fluorescence immunoassay and point-of-care testing (POCT). Through this, we aim to ultimately transform medical diagnosis into a universally available right.
- Main Markets
-
Brazil
Ethiopia
Germany
Mexico
Nigeria
- Main Product
- Attached File
Related Products
Influenza Virus A/B & A Subtype Detection Kit
_2.jpg "H2CAP TEST KIT _DH reagent__1")
H2CAP TEST KIT (DH reagent)
ICG-1000
Dimethyl 2,2'-azobis(2-methylpropionate) CAS NO.2589-57-3
Influenza Virus A Subtype Detection Kit
